These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18618022)

  • 1. Ang II-stimulated migration of vascular smooth muscle cells is dependent on LR11 in mice.
    Jiang M; Bujo H; Ohwaki K; Unoki H; Yamazaki H; Kanaki T; Shibasaki M; Azuma K; Harigaya K; Schneider WJ; Saito Y
    J Clin Invest; 2008 Aug; 118(8):2733-46. PubMed ID: 18618022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating soluble form of LR11, a regulator of smooth muscle cell migration, is a novel marker for intima-media thickness of carotid arteries in type 2 diabetes.
    Jin W; Jiang M; Han X; Han X; Murano T; Hiruta N; Ebinuma H; Piao L; Schneider WJ; Bujo H
    Clin Chim Acta; 2016 Jun; 457():137-41. PubMed ID: 27095609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LR11, an LDL receptor gene family member, is a novel regulator of smooth muscle cell migration.
    Zhu Y; Bujo H; Yamazaki H; Ohwaki K; Jiang M; Hirayama S; Kanaki T; Shibasaki M; Takahashi K; Schneider WJ; Saito Y
    Circ Res; 2004 Apr; 94(6):752-8. PubMed ID: 14764453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of LR11 Attenuates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation With Medial Thickening in Mice.
    Jiang L; Konishi H; Nurwidya F; Satoh K; Takahashi F; Ebinuma H; Fujimura K; Takasu K; Jiang M; Shimokawa H; Bujo H; Daida H
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1972-9. PubMed ID: 27493099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced expression of the LDL receptor family member LR11 increases migration of smooth muscle cells in vitro.
    Zhu Y; Bujo H; Yamazaki H; Hirayama S; Kanaki T; Takahashi K; Shibasaki M; Schneider WJ; Saito Y
    Circulation; 2002 Apr; 105(15):1830-6. PubMed ID: 11956127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of circulating soluble LR11, a regulator of smooth muscle cell migration, are highly associated with atherosclerotic plaques in patients with carotid artery stenosis.
    Harada M; Jiang M; Terai K; Ebinuma H; Hiruta N; Schneider WJ; Sugo N; Nagao T; Bujo H
    Clin Chim Acta; 2019 Mar; 490():69-76. PubMed ID: 30550937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pitavastatin attenuates the PDGF-induced LR11/uPA receptor-mediated migration of smooth muscle cells.
    Jiang M; Bujo H; Zhu Y; Yamazaki H; Hirayama S; Kanaki T; Shibasaki M; Takahashi K; Schneider WJ; Saito Y
    Biochem Biophys Res Commun; 2006 Oct; 348(4):1367-77. PubMed ID: 16919601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LR11/SorLA links triglyceride-rich lipoproteins to risk of developing cardiovascular disease in FH patients.
    Vongpromek R; Bujo H; Hoekstra M; Schneider WJ; van der Zee L; Schinkel AF; Korporaal SJ; Dik WA; Ebinuma H; Jiang M; Verhoeven AJ; Sijbrands EJ; Mulder MT
    Atherosclerosis; 2015 Dec; 243(2):429-37. PubMed ID: 26520897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The soluble form of LR11 protein is a regulator of hypoxia-induced, urokinase-type plasminogen activator receptor (uPAR)-mediated adhesion of immature hematological cells.
    Nishii K; Nakaseko C; Jiang M; Shimizu N; Takeuchi M; Schneider WJ; Bujo H
    J Biol Chem; 2013 Apr; 288(17):11877-86. PubMed ID: 23486467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of circulating soluble LR11 on long-term clinical outcomes in patients with coronary artery disease.
    Ogita M; Miyauchi K; Kasai T; Tsuboi S; Wada H; Naito R; Konishi H; Dohi T; Tamura H; Okazaki S; Yanagisawa N; Shimada K; Suwa S; Jiang M; Bujo H; Daida H
    Atherosclerosis; 2016 Jan; 244():216-21. PubMed ID: 26687467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A secreted soluble form of LR11, specifically expressed in intimal smooth muscle cells, accelerates formation of lipid-laden macrophages.
    Ohwaki K; Bujo H; Jiang M; Yamazaki H; Schneider WJ; Saito Y
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1050-6. PubMed ID: 17332490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating soluble LR11, a novel marker of smooth muscle cell proliferation, is enhanced after coronary stenting in response to vascular injury.
    Ogita M; Miyauchi K; Jiang M; Kasai T; Tsuboi S; Naito R; Konishi H; Dohi T; Yokoyama T; Okazaki S; Shimada K; Bujo H; Daida H
    Atherosclerosis; 2014 Nov; 237(1):374-8. PubMed ID: 25443876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenomedullin is a potent inhibitor of angiotensin II-induced migration of human coronary artery smooth muscle cells.
    Kohno M; Yokokawa K; Kano H; Yasunari K; Minami M; Hanehira T; Yoshikawa J
    Hypertension; 1997 Jun; 29(6):1309-13. PubMed ID: 9180634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biomarkers for Atherosclerotic Diseases: Significance of Intimal Smooth Muscle Cell-Derived Circulating Marker].
    Bujo H
    Rinsho Byori; 2016 Jun; 64(6):651-656. PubMed ID: 30695319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an immunoassay for the quantification of soluble LR11, a circulating marker of atherosclerosis.
    Matsuo M; Ebinuma H; Fukamachi I; Jiang M; Bujo H; Saito Y
    Clin Chem; 2009 Oct; 55(10):1801-8. PubMed ID: 19661140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced circulating soluble LR11 in patients with coronary organic stenosis.
    Takahashi M; Bujo H; Jiang M; Noike H; Saito Y; Shirai K
    Atherosclerosis; 2010 Jun; 210(2):581-4. PubMed ID: 20047743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of valsartan on angiotensin II-induced migration of human coronary artery smooth muscle cells.
    Kohno M; Ohmori K; Nozaki S; Mizushige K; Yasunari K; Kano H; Minami M; Yoshikawa J
    Hypertens Res; 2000 Nov; 23(6):677-81. PubMed ID: 11131281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation.
    Ji Y; Weng Z; Fish P; Goyal N; Luo M; Myears SP; Strawn TL; Chandrasekar B; Wu J; Fay WP
    Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2167-2175. PubMed ID: 27659097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of LR11, a mosaic LDL receptor family member, is markedly increased in atherosclerotic lesions.
    Kanaki T; Bujo H; Hirayama S; Ishii I; Morisaki N; Schneider WJ; Saito Y
    Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2687-95. PubMed ID: 10559012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G-CSF induces the release of the soluble form of LR11, a regulator of myeloid cell mobilization in bone marrow.
    Shimizu N; Nakaseko C; Jiang M; Nishii K; Yokote K; Iseki T; Higashi M; Tamaru J; Schneider WJ; Bujo H
    Ann Hematol; 2014 Jul; 93(7):1111-22. PubMed ID: 24577511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.